Concurrently, it transiently doubles the risk of severe hypoglycemia as patientsbegin to take their newly prescribed medications, nearly all of which in this study wereassociated with heightened hypoglycemia risk (ie, insulin and sulfonylurea). This evidence concerns the gene INS and Hypoglycemia.